This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 4 EPO patents. Top assignees: Aziende Chimiche Riunite Angelini Francesco A.c.r.a.f. S.p.a., Angelini S.p.a.. Active years: 2020-2026.
Company Filing History:
Years Active: 2020-2026
Title: The Innovative Mind of Fabrizio Calisti
Introduction
Fabrizio Calisti, an accomplished inventor based in Rome, Italy, has made significant contributions to the field of pharmaceuticals. With a focus on pain management, his inventions reflect a deep understanding of the complexities involved in medicinal chemistry. With a total of two patents to his name, Calisti continues to innovate in an area that greatly impacts patient care.
Latest Patents
Fabrizio Calisti's latest patents demonstrate his dedication to improving therapeutic options for individuals suffering from pain. The first patent, titled "Pharmaceutical Composition for the Treatment of Pain," pertains to a unique pharmaceutical composition combining trazodone or a salt thereof, and gabapentin or a salt or prodrug thereof. This combination is noted for its synergistic effect in pain treatment. His second patent, "Combination of Trazodone and Gabapentin for the Treatment of Pain," echoes this formulation, emphasizing the effectiveness of this combination in managing pain more efficiently.
Career Highlights
Calisti is currently employed at Aziende Chimiche Riunite Angelini Francesco A.c.r.a.f. S.p.a., a well-respected company in the pharmaceutical industry. His work involves not only the development of innovative pain management solutions but also the ongoing research into pharmaceutical compositions that can enhance patient outcomes. His contribution to medicinal developments has positioned him as an influential figure in the sector.
Collaborations
Throughout his career, Fabrizio has collaborated with esteemed colleagues, including Beatrice Garrone and Lucia Durando. Working alongside such talented individuals has fostered an environment of creativity and innovation, allowing Calisti to push the boundaries of pharmaceutical development. Their collective expertise enhances the effectiveness of their work, creating greater opportunities for scientific breakthroughs.
Conclusion
Fabrizio Calisti stands out as a notable inventor whose work focuses on significant advancements in pain treatment. With two patents under his belt, he exemplifies the spirit of innovation within the pharmaceutical industry. His ongoing efforts at Aziende Chimiche Riunite Angelini Francesco A.c.r.a.f. S.p.a. and collaborations with skilled colleagues underscore his commitment to improving healthcare solutions. As the field of pain management continues evolving, Calisti’s contributions are sure to inspire future innovations.